Jounce, ObsEva file for IPOs

Cancer immunotherapy company Jounce Therapeutics Inc. (Cambridge, Mass.) and reproductive health play ObsEva S.A. (Geneva, Switzerland) each filed for

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE